Head to head
POSCO vs Nucor
Side-by-side on the measures that matter, with a plain-English read. Full detail: PKX · NUE
PKX
POSCO
44.84-5.34%
1-year price shape — -15% over the period
Quant Rating D · 24/100
vs
NUE
Nucor
239.62-3.16%
1-year price shape — +64% over the period
Quant Rating C · 91/100
1-year performance, rebased to 100
Nucor edges it on the scoreable measures. Nucor has the highest Quant Rating (91); Nucor has done best over the past year (+64%); Nucor earns the most per share.
| PKX | NUE | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Steel |
| Last price | 44.84 | 239.62 |
| Change today | -5.34% | -3.16% |
| 1-year return | -14.7% | +64.3% |
| Market cap | $13.56B | $53.90B |
| 52-week range | 44.60 – 91.40 | 149.11 – 287.70 |
| Valuation | ||
| P/E (TTM) | 13.80 | 15.26 |
| P/E percentile, own 5-yr range | 31st | 68th |
| P/B | 0.28 | 2.36 |
| Dividend yield | 3.39% | 0.93% |
| Profitability & growth | ||
| EPS (TTM) | 1.71 | 7.52 |
| Net profit (TTM) | $517.25M | $1.69B |
| Revenue (TTM) | $71.13T | $38.83B |
| Provider revenue period date | 2026-06-29 | 2026-10-02 |
| Revenue growth (YoY) | +9.7% | +32.0% |
| Gross margin | 7.9% | 17.3% |
| Operating margin | 3.2% | 13.3% |
| Net margin | 1.9% | 9.2% |
| Free cash flow (TTM) | $-2.56T | $2.66B |
| Provider cash-flow period date | 2026-06-29 | 2026-10-02 |
| Ownership & sentiment | ||
| Institutional ownership | 35.7% | 80.7% |
| Insider activity (12mo) | 0 buy / 0 sell | 25 buy / 25 sell |
| Short interest (% of float) | 0.3% | 1.9% |
| Analyst consensus | -- | 100% buy (10) |
| Analyst price target | -- | $308 (+28%) |
| StockVane view | ||
| StockVane Quant Rating | D (24) | C (91) |
| Company | ||
| Employees | 42,873 | 33,000 |
| Founded | 1968 | 1958 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.